share_log

Recursion Pharmaceuticals | 144/A: Others

Recursion Pharmaceuticals | 144/A: Others

Recursion Pharmaceuticals | 144/A:其他
美股sec公告 ·  04/16 17:01
Moomoo AI 已提取核心訊息
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 25,000 Class A shares on 04/16/2024, as per the latest filing. The shares, valued at approximately $191,658.73, were originally acquired on 04/20/2021 through a pre-IPO option exercise directly from the issuer. The transaction is part of a planned sale that was adopted on 03/01/2023. Over the past three months, Secora Michael has sold a total of 150,000 shares, generating gross proceeds of $1,562,683.24.
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 25,000 Class A shares on 04/16/2024, as per the latest filing. The shares, valued at approximately $191,658.73, were originally acquired on 04/20/2021 through a pre-IPO option exercise directly from the issuer. The transaction is part of a planned sale that was adopted on 03/01/2023. Over the past three months, Secora Michael has sold a total of 150,000 shares, generating gross proceeds of $1,562,683.24.
根據最新文件,Recursion Pharmicals, Inc.高管塞科拉·邁克爾定於2024年4月16日出售25,000股A類股票。這些股票的價值約爲191,658.73美元,最初是在2021年4月20日通過首次公開募股前的期權行使直接從發行人手中收購的。該交易是2023年1月3日通過的計劃出售的一部分。在過去的三個月中,Secora Michael共出售了15萬股股票,總收益爲1,562,683.24美元。
根據最新文件,Recursion Pharmicals, Inc.高管塞科拉·邁克爾定於2024年4月16日出售25,000股A類股票。這些股票的價值約爲191,658.73美元,最初是在2021年4月20日通過首次公開募股前的期權行使直接從發行人手中收購的。該交易是2023年1月3日通過的計劃出售的一部分。在過去的三個月中,Secora Michael共出售了15萬股股票,總收益爲1,562,683.24美元。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息